Neoplasms

All Conditions

Behaviors and Mental Disorders

Rare Diseases

Glioma

Caregiver Burden

Neoplasms, Neuroepithelial

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms by Histologic Type

Neoplasms, Glandular and Epithelial

Neoplasms, Nerve Tissue

Stress, Psychological

Behavioral Symptoms

Neuroepithelioma

Patient participants will fill out questionnaires about emotional and physical health with responses used to develop an individualized survivorship plan conducted through 1x monthly virtual or in-clinic check-ins as well as GROW support meetings as needed for 6 months.

Caregiver participants will fill out questionnaires used to develop patient individualized survivorship plan and participate in 1x monthly check-in meetings with patients or separately for 6 months.

Follow-up survivorship care plan for patients and caregivers

GROW (Glioma Specialists Reaching Out With Support) Support Program

Timothy S Sannes, PhD

This research study is being done to test a participant and caregiver-driven model of follow-up survivorship care,GROW Support (Glioma Specialists Reaching Out With Support), for post-treatment, low grade glioma patients.

This research study is a Feasibility Study, which examines if a supportive intervention for people with low grade gliomas (LGGs) and their caregivers is acceptable and feasible to patients and their caregivers.

The research study procedures include: screening for eligibility and study interventions including filling out questionnaires and virtual or in-clinic supportive follow up visits to identify additional supportive needs that may arise.

Participants will be in this research study for up to 6 months.

It is expected that about 40 people will take part in this research study.

The Levitan-Zabin Fund for GROW Support is supporting this research study by providing funds for research team members to do this study.

GROW (Glioma Specialists Reaching Out With Support) Support

GROW Support (Glioma Specialists Reaching Out With Support): Assessment of a Comprehensive Support Program for Low Grade Glioma Patients Post-treatment

The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: \[contact information for Sponsor Investigator or designee\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Primary outcome is feasibility as defined by 60% of the eligible participants and their caregivers being recruited into the study and completing the initial assessment and associated survivorship plan

Acceptability of this supportive program ("GROW Support") for patients and their caregivers will be assessed by the Abbreviated Acceptability Rating Profile and based on in-depth semi-structured interview with one of the study investigators.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
GROW (Glioma Specialists Reaching Out With Support) Support	NCT05233215	Low-grade Gliom... Survivorship Care Giving Bur...	GROW (Glioma Sp...	18 Years -	Dana-Farber Cancer Institute
GROW (Glioma Specialists Reaching Out With Support) Support	NCT05233215	Low-grade Gliom... Survivorship Care Giving Bur...	GROW (Glioma Sp...	18 Years -	Dana-Farber Cancer Institute

Spots Global Cancer Trial Database for grow (glioma specialists reaching out with support) support program